How Trump’s Choice to Lead FDA Aligns With RFK Jr.’s Views on Health and Transparency

RFK Jr. and Marty Makary are both critics of COVID-19 mandates and advocates for removing chemicals and toxins from America’s food supply.

Dr. Marty Makary, surgeon, professor at Johns Hopkins University, and author of “Blind Spots: What Medicine Gets Wrong, and What It Means for Our Health,” gives an interview on EpochTV's "American Thought Leaders" on Sept. 17, 2024.

Dr. Marty Makary, President-elect Donald Trump’s choice to lead the Food and Drug Administration (FDA), and Robert F. Kennedy Jr., his nominee to head the Department of Health and Human Services (HHS), are both critics of COVID-19 mandates, advocates for removing chemicals and toxins from America’s food supply, and proponents of greater transparency in medicine.

If both men are confirmed by the Senate in January 2025, Kennedy will serve as Makary’s boss, as the FDA is one of 13 agencies under HHS.